21-Adamantane-1'-carboxylate steroid compositions

Details 21-Adamantane-1'-carboxylate steroid compositions 21-Adamantane-1'-carboxylate steroid compositions

1975-11-19

1977-04-05

Roberts, Elbert L.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

A61K 3156

Patent

active

040162710

ABSTRACT:
The Specification describes a method of systemically treating immunological disorders or inflammatory disorders having a significant immunological component which comprises administering to a subject suffering from such a disorder an initial dosage in the case of a human adult subject of 50 to 500 mg of from more than betamethasone 21-adamantane-1'-carboxylate, dexamethasone 21-adamantane-1'-carboxylate or a corresponding 11-ketone, or in the case of other subjects, an equivalent dosage calculated on the body weight of the subject. The Specification further describes pharmaceutical and veterinary compositions for use in the above method, each dosage unit containing 50 to 500 mg of the 21-adamantane-1'-carboxylate steroid.

REFERENCES:
patent: 3857941 (1974-12-01), Ercoli et al.

Affiliated with

Also associated with

Rating

21-Adamantane-1'-carboxylate steroid compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 21-Adamantane-1'-carboxylate steroid compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 21-Adamantane-1'-carboxylate steroid compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2266283